Jump to content

Search the Community

Showing results for tags 'clinical trial'.

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


  • Discussion
    • Welcome and Newly Diagnosed
    • IBS Discussion and Symptoms
    • Diarrhea predominant IBS (IBS-D)
    • Constipation predominant IBS (IBS-C)
    • IBS Diet, low FODMAP Diet and Nutrition
    • IBS Medications, Medical Foods and Fecal Microbiota Transplantation (FMT)
    • Women's Health Issues
    • IBS Patient Stories
    • IBS Podcasts and Videos
    • IBS Clinical Research Trials - Participants Wanted!
    • IBS News Articles and Research Results
    • IBS Newsfeed
    • IBS Twitter feed
    • Announcements
    • We Remember
  • Member Area
    • Products We Love

Find results in...

Find results that contain...

Date Created

  • Start


Last Updated

  • Start


Filter by number of...

Found 2 results

  1. Could cancer anti-sickness drug end the misery for IBS patients? Could a commonly-prescribed anti-sickness drug be the answer for the 1.3 million people in the UK who suffer the pain and misery of irritable bowel syndrome with diarrhoea (IBS-D)? A nationwide clinical trial led by researchers at The University of Nottingham and funded by the National Institute for Health Research (NIHR) will assess the medication ondansetron, which is currently used by doctors to help cancer patients cope with the nausea and vomiting associated with chemotherapy, radiotherapy and surgery. The research will aim to establish whether a much lower dose of the drug could also be a successful treatment for the abdominal pain and urgent bowel movements typically experienced by IBS patients. >> Full story: https://www.nottingham.ac.uk/news/pressreleases/2018/december/could-cancer-anti-sickness-drug-end-the-misery-for-ibs-patients.aspx >. Clinical trial listing: https://www.ibspatient.org/community/topic/32229-triton-ibs-clinical-trial-for-ondansetron/
  2. Research study: A Pilot Study to Evaluate Fecal Microbiota Transplantation in Irritable Bowel Syndrome Location: Boston, Massachusetts Inclusion Criteria: IBS with diarrhea The study is to evaluate whether we can change the microbiome of individuals with IBS using a healthy donor. We then would like to see whether if we are able to change the microbiome, if there's a resulting improvement in symptoms. We randomize people to receive either a fecal transplant or a placebo fecal transplant. People are also receiving an antibiotic either rifaximin, a combination of Cipro/flagyl or no antibiotic as a pre-treatment. The capsule form of fecal matter transplant (FMT) is being used. Contact: Vivian Cheng 617.667.0682 vcheng2@bidmc.harvard.edu Principal Investigator: Anthony Lembo, MD, Beth Israel Deaconess Medical Center More clinical trials listed here: https://www.ibspatient.org/clinical-trials
  • Create New...